Karyopharm Therapeut
(KPTI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 75 | 150 | 0 | 16 | 21 |
| Gross Profit | 75 | 150 | N/A | 16 | 21 |
| Operating Expenses | 30,685 | 33,163 | 26,150 | 25,958 | 19,765 |
| Operating Income | -30,610 | -33,013 | -26,150 | -25,942 | -19,744 |
| Other Income | 237 | 318 | 83 | 14 | 20 |
| Pre-tax Income | -30,373 | -32,695 | -26,067 | -25,928 | -19,724 |
| Net Income Continuous | -30,373 | -32,695 | -26,067 | -25,928 | -19,724 |
| Net Income | $-30,373 | $-32,695 | $-26,067 | $-25,928 | $-19,724 |
| EPS Basic Total Ops | -12.74 | -13.79 | -11.09 | -12.14 | -9.15 |
| EPS Basic Continuous Ops | -12.75 | -13.73 | -11.07 | -12.17 | -9.08 |
| EPS Diluted Total Ops | -12.74 | -13.79 | -11.09 | -12.14 | -9.15 |
| EPS Diluted Continuous Ops | -12.75 | -13.73 | -11.07 | -12.17 | -9.08 |
| EBITDA(a) | $-29,918 | $-32,272 | $-25,783 | $-25,808 | $-19,638 |